This webinar is now available on our YouTube channel.
On September 30th at 7 pm ET, 4 pm PT, please join Dr. Lisa Boyette, Recursion Pharmaceuticals’ Senior Director of Medical Affairs, who will be sharing details of the new REC-994 trial for cavernous malformation. REC-994 is the first industry-sponsored medicine to reach trials for our families, and we are thrilled to share information about the Phase 2 launch with our community. Dr. Boyette will provide an overview of clinical trials in general and will offer specifics of the REC-994 trial, including the nature of the medicine, where the first sites will be, and who and how many will be eligible to participate.
This webinar was recorded and can be viewed on our YouTube Channel: https://youtu.be/DTri7rCIqjo
